875339-90-5 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
4-Chloro-6-(tributylstannyl)-thieno[3,2-d]pyrimidine is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and potential biological activities make it a valuable component in the development of new drugs and agricultural chemicals.
Used in Anticancer Research:
4-Chloro-6-(tributylstannyl)-thieno[3,2-d]pyrimidine is used as a potential anticancer agent in research. Its biological activities have been studied for their potential to target and inhibit cancer cells, offering a new avenue for cancer treatment.
Used in Antimicrobial Research:
In addition to its potential anticancer properties, 4-Chloro-6-(tributylstannyl)-thieno[3,2-d]pyrimidine is also used as a potential antimicrobial agent. Its ability to target and inhibit the growth of microorganisms makes it a candidate for the development of new antimicrobial drugs to combat drug-resistant infections.
Used in Medicinal Chemistry and Drug Development:
4-Chloro-6-(tributylstannyl)-thieno[3,2-d]pyrimidine is of interest to researchers and chemists in the field of medicinal chemistry and drug development. Its unique structure and potential for various applications make it a valuable tool for exploring new therapeutic approaches and advancing the understanding of molecular interactions in biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 875339-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,3,3 and 9 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 875339-90:
(8*8)+(7*7)+(6*5)+(5*3)+(4*3)+(3*9)+(2*9)+(1*0)=215
215 % 10 = 5
So 875339-90-5 is a valid CAS Registry Number.
875339-90-5Relevant academic research and scientific papers
INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
-
Page/Page column 133, (2010/02/15)
The invention relates to the inhibition of vascular endothelial growth factor (VEGF) receptor signaling and hepatocyte growth factor (HGF) receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions
Thienopyrimidines useful as Aurora kinase inhibitors
-
Page/Page column 112, (2008/06/13)
The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasess herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.
